Having trouble accessing articles? Reset your cache.

Actonel risedronate: Post-marketing study data

A task force of the American Society for Bone and Mineral Research reported a review of both published and unpublished data suggesting that the risk of atypical femoral fractures increases with the duration

Read the full 331 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE